The QualityStocks Daily Wednesday, January 17th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(MIMO) $0.2200 +186.09%

SmallCapRelations(FEMFF) $0.2450 +57.76%

QualityStocks(AMMJ) $0.0079 +46.30%

The QualityStocks Daily Stock List

American Cannabis Company (AMMJ)

QualityStocks, Promotion Stock Secrets, InvestorPlace,, CFN Media Group, Money Morning, Wealth Insider Alert, Stock News Now, The Street, Cannabis Financial Network News, Market Intelligence Center Alert, TheOTCInvestor, Energy & Resources Digest, Daily Trade Alert, Wall Street Daily and MarketBeat reported earlier on American Cannabis Company (AMMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Cannabis Company Inc. (OTCQB: AMMJ) is a company engaged in the provision of solutions for businesses operating in the regulated cannabis industry in Canada and the United States.

The firm has its headquarters in Lakewood, Colorado and was incorporated in 2001. It operates as part of the consulting services industry, under the industrials sector. The firm serves consumers in the U.S. and Canada.

The enterprise provides clean, green solutions to existing and aspiring participants in the cannabis and hemp industries as well as consulting services for firms associated with the cannabis industry in different stages of development, such as cannabis license applications, business planning, growth strategies and monitoring, as well as cultivation build-out oversight, cannabis regulatory compliance, and compliance audit services. It also sells products and equipment used in the cultivation, processing, transportation or retail sale of cannabis, such as High Density Cultivation System, which ensures that space is used in an efficient manner; The Satchel, a pouch-like case designed as a child-proof exit package solution for the regulated cannabis industry; The Cultivation Cube, a self-contained and scalable cultivation system; SoHum Living Soil, a just-add-water soil; and other products for cultivation operations, medicinal and recreational cannabis dispensary operations, and infused-products. In addition to this, the enterprise offers advisory and consulting services to design industry-specific products and facilities; and manages a strategic group partnership that offers customer products commonly used in the industry.

The company remains committed to better meeting consumer needs via its products and generating value for its shareholders.

American Cannabis Company (AMMJ), closed Wednesday's trading session at $0.0079, up 46.2963%, on 15,700,896 volume. The average volume for the last 3 months is 5.424M and the stock's 52-week low/high is $0.005/$0.087.

Kintara Therapeutics (KTRA)

QualityStocks, TradersPro, The Online Investor, MarketBeat, The Stock Dork, StockEarnings, Smart money trading, Profitable Trader Authority, PennyStockScholar, pennystockprophet, OTCtipReporter, MarketClub Analysis, InvestorPlace and Early Bird reported earlier on Kintara Therapeutics (KTRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kintara Therapeutics, Inc. (NASDAQ: KTRA) (OTC: DMPWW) (FRA: 3DM) is a clinical stage drug development firm that is engaged in the development and commercialization of anti-cancer therapies for the treatment of cancer.

The firm has its headquarters in San Diego, California and was incorporated in 2009, on June 24th by William J. Garner, Dennis M. Brown and Jeffrey A. Bacha. Prior to its name change in August 2020, the firm was known as DelMar Pharmaceuticals Inc. It operates as part of the scientific research and development services industry and serves consumers around the globe. The firm has two companies in its corporate family.

The company is focused on identifying commercial and clinical-stage compounds and establishing a scientific rationale for developing orphan drug indications. It has teamed up with outstanding clinical research and academic institutions across the globe to support the development of its cancer treatments. It is party to a strategic collaboration with Guangxi Wuzhou Pharmaceutical Co. Ltd, which entails manufacturing and selling VAL-083 in China.

The enterprise’s product pipeline comprises of two late-stage therapeutics, including a photodynamic therapy dubbed REM-001 for the treatment of cutaneous metastatic breast cancer; and a DNA-targeting agent dubbed VAL-083 for the treatment of drug-resistant solid tumors like diffuse intrinsic pontine glioma, non-small cell lung cancer, ovarian cancer and glioblastoma multiforme.

The company recently announced its financial results for its fiscal year ended June 2021, with its CEO noting that the company was well-positioned both on its corporate and clinical development front, having entered into purchase agreements with investors to raise monies which will be used for the company’s corporate working capital needs and ongoing clinical studies.

Kintara Therapeutics (KTRA), closed Wednesday's trading session at $0.158, up 24.5075%, on 47,384,473 volume. The average volume for the last 3 months is 97,386 and the stock's 52-week low/high is $0.1225/$7.65.

Snipp Interactive (SNIPF)

InvestorIntel reported earlier on Snipp Interactive (SNIPF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snipp Interactive Inc. (OTC: SNIPF) is a loyalty and promotions technology firm engaged in the provision of mobile marketing and loyalty services.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2010, on January 21st by Ritesh Bhavnani, Rahoul Roy and Atul Sabharwal. It operates as part of the advertising agencies industry, under the communication services sector. The firm serves consumers around the globe, with a focus on those in Canada, Ireland and the United States.

The enterprise’s offerings include SnippWin, a promotion and sweepstakes platform offering a range of promotions from contests and simple sweepstakes to instant win programs and tiered, multi-level games; SnippCheck, a receipt processing system that permits brands to run retail-agnostic purchase or non-purchase promotions; and SnippInsights that enables intelligent advertising and marketing decision making. It also offers SnippLoyalty, a cloud-based customer loyalty program software; SnippRebates, a SaaS platform that allows brands to set up and manage single-instance or cross-portfolio rebate marketing programs; SnippRewards, a rewards platform that offers various rewards, including movie tickets, PayPal, and other money back mechanisms; and Snipp Payments Media Network, an advertising network across banks' digital channels. In addition to this, the enterprise provides sweepstakes services, including legal compliance administration, strategy, rewards,program build, customer support and omnichannel activation. It serves brands and related marketing, advertising agencies, and promotions agencies.

The company, which recently reported its latest financial results showing growth in its revenues, remains focused on developing new revenue streams and future growth drivers. This is in addition to generating additional value for its shareholders.

Snipp Interactive (SNIPF), closed Wednesday's trading session at $0.121, off by 0.247321%, on 277,448 volume. The average volume for the last 3 months is 4,645 and the stock's 52-week low/high is $0.0088/$0.15.

Haivision Systems (HAIVF)

We reported earlier on Haivision Systems (HAIVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Haivision Systems Inc. (OTC: HAIVF) (TSE: HAI) (FRA: H8A) is a company engaged in the provision of infrastructure solutions.

The firm has its headquarters in Montreal, Canada and was incorporated in 2004, on April 26th by Miroslav Wicha. Prior to its name change in June 2004, the firm was known as Haitek Vision Inc. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers globally.

The enterprise’s offerings include Haivision Kraken, a video transcoder for mission-critical ISR, situational awareness, and field monitoring applications; and Makito Series video encoders and decoders for end-to-end transport of secure and high-quality HD video; video transmitters and mobile encoders for video contribution over bonded unmanaged IP networks. It also offers Haivision Media Platform that manages, shares, and delivers secure corporate communications, real-time video feeds, and broadcast IPTV; Haivision Hub for Government, a video network service for live and low latency video streaming between government agencies and public cloud delivery services; and Haivision EMS, an element management system for centrally managing and monitoring encoders and decoders. In addition to this, the enterprise offers Haivision Play, series of high-performance video player applications for desktops, mobile devices, managed set-top boxes; Haivision Play Pro, a free application for securely playing or streaming live SRT feeds from anywhere over the internet; and Haivision SRT Gateway, a broadcast solution for secure routing of live video streams across different types of IP networks. It serves enterprise, broadcast, medical, government, and military and defense industries.

The company is set to take part in the Integrated Systems Europe (ISE) 2024 in Barcelona. It plans to showcase its video wall solution, powered by Haivision Command 360, designed to empower security and network operation centers and real-time crime centers. This may open it up to new growth and investment opportunities.

Haivision Systems (HAIVF), closed Wednesday's trading session at $3.1889, off by 9.6654%, on 11,307 volume. The average volume for the last 3 months is 57,040 and the stock's 52-week low/high is $2.33/$3.5301.

Drone Delivery Canada (TAKOF)

QualityStocks, TradersPro and InvestorPlace reported earlier on Drone Delivery Canada (TAKOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Drone Delivery Canada Corp (OTCQX: TAKOF) (CVE: FLT) (FRA: ABBA) is a developmental technology firm focused on designing, developing and implementing a commercial drone-based logistics platform.

The firm has its headquarters in Vaughan, Canada and was incorporated in 2011, on February 2nd. It operates as part of the computer hardware industry, under the technology sector. The firm serves consumers across the globe, with a focus on Canada.

The company’s vision is to be the premier drone delivery company worldwide. It commercializes its technology to create new and innovative logistics platforms for firms and government agencies.

The enterprise’s logistics infrastructure solution is an integrated turnkey logistics platform, which include automated DroneSpot depots, industrial-grade drones, a detect and avoid radar system, automated battery management systems, and proprietary FLYTE software to integrate a range of components into a solution. It provides a few service options such as Depot to Depot, which focuses on rural applications offering services from warehouse to warehouse and Depot to Consumer providing logistics services from a retailer and warehouse direct to a consumer's home or business location. The enterprise serves indigenous and non-indigenous remote communities; governments; commercial and industrial applications, such as emergency services, medical, mining, oil and gas, last-mile delivery, agriculture, parcel delivery, postal mail, and military/security.

The firm recently announced that its DroneCare project with Halton Healthcare Services Corporation was commercially operational. This move will demonstrate the healthcare industry's ability to leverage drone technology for the benefit of patients and medical professionals. It may also bring in additional revenues into the firm while extending its consumer reach.

Drone Delivery Canada (TAKOF), closed Wednesday's trading session at $0.2222, off by 3.3913%, on 155,472 volume. The average volume for the last 3 months is 96,352 and the stock's 52-week low/high is $0.109/$0.3914.

SYLA Technologies (SYT)

StreetInsider, SmarTrend Newsletters, Louis Navellier, The Street, Market Report, StreetAuthority Daily, Wyatt Investment Research, Barchart, Uncommon Wisdom, Short Term Wealth, MarketClub Analysis, Daily Profit, AllPennyStocks, MarketBeat, Zacks, TopStockAnalysts, InvestorPlace, BUYINS.NET, Wall Street Grand, Daily Trade Alert, Energy and Capital,, Investopedia, The Motley Fool, Schaeffer's, Street Insider, Navellier Growth, Money and Markets, Trader Prep, Wealth Daily, CNBC Breaking News, Daily Wealth, MarketWatch, Investment U, FreeRealTime, Market Intelligence Center Alert, Investiv, Stocks To Watch, News, Investors Alley, Market Authority and equities Canada reported earlier on SYLA Technologies (SYT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SYLA Technologies Co. Ltd (NASDAQ: SYT) is a company focused on the development, construction, sale and management of apartments in Japan.

The firm has its headquarters in Tokyo, Japan and was incorporated in 2009, on March 3rd. Prior to its name change, the firm was known as SYLA Holdings Company Limited. It operates as part of the software-application industry, under the technology sector. The firm mainly serves consumers in Japan.

The company’s mission is to democratize real estate investment around the world through technology and asset management. It focuses on the land purchase, design, construction, operation, and maintenance of solar power plants.

The enterprise offers real estate crowdfunding services on the Rimawari-kun platform; designs, develops, manufactures, and sells computers for artificial intelligence (AI) and graphics processing; and offers real estate leasing, brokerage, and management services. It also offers Rimawari-kun AI, a system that automatically collects various real estate data found online and compiles indexes; engages in electricity brokerage, renewable energy trading, and trade brokerage activities; and is involved in real estate investment, machine learning algorithms, and business systems using Rimawari-kun. In addition to this, the enterprise offers consulting on real estate investment and asset management; operates and sells renewable energy-related products; sells and maintains solar and biomass power generation equipment; and provides consulting on business automation and AI system implementation for corporations.

The firm, which recently concluded the acquisition of common shares of Riberesute Corp to become the largest shareholder, continues to focus on enhancing shareholder value and striving for improved profitability in its management endeavors.

SYLA Technologies (SYT), closed Wednesday's trading session at $4.82, up 2.5532%, on 63,582 volume. The average volume for the last 3 months is 63,726 and the stock's 52-week low/high is $2.80/$8.74.

Sokoman Minerals (SICNF)

We reported earlier on Sokoman Minerals (SICNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sokoman Minerals Corp (OTCQB: SICNF) (CVE: SIC) (FRA: 3PJ1) is an exploration-stage firm focused on exploring for mineral properties in Canada.

The firm has its headquarters in Toronto, Canada and was incorporated in 2006, on June 7th. Prior to its name change in February 2019, the firm was known as Sokoman Iron Corporation. It operates as part of the gold industry, under the basic materials sector. The firm mainly serves consumers in Canada.

The company primarily explores for gold and iron deposits. Its flagship project is the Moosehead gold project, which comprises of 98 claims that cover an area of 2,450 hectares and is located in north-central Newfoundland, Canada. Its other projects include Kepenkeck Gold, Crippleback, East Alder, Fleur de LysIron Horse, Golden Hope-Kraken Pegmatite, and Grey River Gold. The Kepenkeck Gold property, made up of 595 claims, is situated in east-central Newfoundland. The East Alder project comprises of 30 claims while the Fleur de Lys Project is made up of more than 1,891 claims (47,275 hectares) on the BaieVerte Peninsula of Newfoundland. The Grey River property in southern Newfoundland, comprises of 324 claims (8,100 ha) in seven licenses, centered on the community of Grey River. The Golden Hope property is a 3,176-claim (79,400 hectares), 18 licenses and is located in southwestern Newfoundland. The Iron Horse project is located roughly 120km northeast of Labrador City, Labrador.

The enterprise, which is party to a definitive agreement with Piedmont Lithium Inc. and Benton Resources Inc. to acquire interest in the Killick lithium project, remains committed to advancing its exploration efforts at the aforementioned project and creating value for its shareholders.

Sokoman Minerals (SICNF), closed Wednesday's trading session at $0.0494, up 0.816327%, on 355,290 volume. The average volume for the last 3 months is 1.96M and the stock's 52-week low/high is $0.0351/$0.2386.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, The Street, StocksEarning, MarketBeat, Daily Trade Alert, Trades Of The Day, Wealth Insider Alert, QualityStocks, The Online Investor, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, StockEarnings, BUYINS.NET, Zacks, The Wealth Report, Investopedia, Top Pros' Top Picks, Stock Up Featured, InvestmentHouse, Cabot Wealth, Daily Profit, The Rich Investor, Early Bird, InsiderTrades, Jim Cramer, Wall Street Window, VectorVest, 24/7 Trader, InvestorsObserver Team, InvestorsUnderground, Money Morning, Small Cap Firm, TheTradingReport and Stock Gumshoe reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

With the prospect of a potential November vote in Florida on cannabis legalization, a GOP legislator, Representative Ralph Massullo, has introduced a measure that would establish strict restrictions on THC potency in the event of voter approval. Introduced last week, Massullo’s measure suggests a THC cap significantly lower than the prevailing limits in most cannabis markets.

The proposed limitations would become effective 30 days after voters endorse any future constitutional amendment endorsing legalization. The measure proposes a 10% THC limit for smoking-related marijuana products and a 60% limit for other cannabis products, such as extracts. The highest amount of THC allowed in edibles under this legislation would be 200 milligrams, with a 10-milligram cap on each serving.

Such stringent limits could pose significant challenges in commerce and logistics within the potential recreational cannabis market, likely drawing backlash from stakeholders, advocates and consumers. Notably, the average THC content in marijuana flower sold at recreational or medical dispensaries usually ranges between 20% and 30%. This mirrors the existing scenario in the state’s medical marijuana market, where the measure’s focus on “recreational use potency limits” may create complications by establishing different THC regulations for recreational consumers and patients.

Contrastingly, Florida’s current medical marijuana dosage limits, revised in 2022 amid some controversy, do not depend on THC percentage. The bill introduces a complex definition of potency, specifically addressing cannabis dispensed to a caregiver or patient in terms of relative cannabinoid strength and total THC content.

The bill seems to specifically target the impending legalization vote initiative awaiting the outcome of the state’s Supreme Court ruling. A legal challenge against the reform put up by Smart and Safe Florida, which gathered almost a million signatures to qualify for the ballot, is being led by the state’s attorney general, Ashley Moody. Even though the court heard oral arguments in November, its position on the initiative is still unknown.

Crucially, the ballot measure itself does not establish THC potency limits. Therefore, Massullo’s bill could potentially preempt the initiative, preventing voters from deciding on the matter independently. This legislative strategy is reminiscent of moves made by Ohio GOP legislators after voters approved a recreational cannabis legalization bill. In Ohio, efforts are underway to amend the marijuana law significantly, with similar discussions about implementing THC potency limits.

Meanwhile, a Florida GOP senator filed a measure last month that would permit approved medical cannabis companies to qualify for tax deductions from the state otherwise not allowed at the national level due to code 280E.

The struggle for reforms isn’t only playing out in Florida. Even jurisdictions where companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) have their own issues and efforts to bring incremental improvements are underway.

Cronos Group Inc. (CRON), closed Wednesday's trading session at $2.01, off by 1.4706%, on 2,361,679 volume. The average volume for the last 3 months is 531,173 and the stock's 52-week low/high is $1.64/$2.64.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Trades Of The Day, The Street and Prism MarketView reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In the last couple of years, ketamine has been used to treat depression, with ketamine clinics across Canada and the United States administering the drug for the management of anxiety, depression and post-traumatic stress disorder.

Ketamine is a dissociative drug commonly used as an anesthetic that causes an individual to lose consciousness and relieve pain. In high doses, ketamine can create neuroplasticity and induce psychedelic experiences. Below, we look at some studies conducted in 2023 that have explored ketamine’s effectiveness in treating a range of mental-health conditions.

Ketamine for the prevention of psychiatric disorders induced by stress

A study carried out by a group of researchers, among them Briana K. Chen, looked into how ketamine could improve stress resilience and possibly aid in the prevention of stress-related psychiatric disorders. The researchers discovered that ketamine could strengthen the brain’s resilience to stress by acting as a prophylactic.

Ketamine for the treatment of depression

Research by Kai Zhang and others looked into ketamine’s antidepressant potential, focusing on its efficacy following the administration of a single dose. The researchers noted the drug’s dual nature; its therapeutic effects on mood and its ability to bring about dissociation.

The researchers also highlighted the need for further studies into ketamine’s mechanisms for the development of more effective and safer treatments for depression.

Ketamine infusions for the management of treatment-resistant bipolar depression

Research by Farhan Fancy and others examined ketamine’s effectiveness in managing treatment-resistant bipolar depression. The study, carried out in a community clinic setting, observed how patients responded to ketamine therapy.

The researchers noted that more than 30% of patients had a positive response to the drug, with about 20% of patients also achieving remission. These findings signal a considerable reduction in symptom severity.

Ketamine for the treatment of cocaine-use disorder

Research led by Zhenxiang Gao used artificial intelligence (AI) to evaluate the drug’s effectiveness in treating cocaine-use disorder. The study found that patients with cocaine-use disorder demonstrated considerable improvement when ketamine was administered.

This research illustrates AI’s role in healthcare and provides new insights into broader therapeutic applications for ketamine.

Ketamine as a second-line therapy for epilepsy in children

Research by Silvia Burrati examined ketamine’s use in children who experienced benzodiazepine-refractory convulsive status epilepticus.

This study is particularly important because this form of epilepsy is a huge challenge in pediatric neurology, given its resistance to conventional therapies. The researchers determined that ketamine posed fewer side effects and could rapidly affect the brain, which helped address seizures effectively.

It is important to note these mental-health benefits cannot be obtained from the recreational use of ketamine. The drug also has a high potential for abuse, which can lead to severe cognitive issues, death of brain cells and bladder issues. This could largely be the reason why many psychedelics companies such as Compass Pathways PLC (NASDAQ: CMPS) are focusing their drug-development efforts on the clinical rather than recreational use of psychedelics.

Compass Pathways PLC (CMPS), closed Wednesday's trading session at $8.2, off by 1.7964%, on 270,126 volume. The average volume for the last 3 months is 116,052 and the stock's 52-week low/high is $5.01/$11.1499.

Kandi Technologies Group Inc. (KNDI)

Green Car Stocks, MarketClub Analysis, QualityStocks, InvestorPlace, Schaeffer's, The Street, StockMarketWatch, Hit and Run Candle Sticks, StreetInsider, TraderPower, Alternative Energy, Jason Bond, Greenbackers, GreatStockPix, Wall Street Resources, MarketBeat, Investing Futures, TradersPro, China Stock Alerts, BUYINS.NET,, Money Morning, Penny Stock Rumble, GreenCarStocks, ProfitableTrading, SmarTrend Newsletters, StreetAuthority Daily, Trades Of The Day, TradingMarkets, The Wealth Report, TopStockAnalysts, FeedBlitz, Energy and Capital, Dynamic Wealth Report, DrStockPick, Money and Markets, CRWEWallStreet, Market Report, CRWEPicks, CRWEFinance, CoolPennyStocks, ChartAdvisor, Weekly Wizards, BullRally, BestOtc, Barchart, Daily Trade Alert, Stock Traders Chat, Profit Confidential, PennyTrader Publisher, PennyToBuck, PennyStockVille, PennyOmega, PennyInvest, Rick Saddler, SmallCapNetwork, Street Insider, SmallCapVoice, HotOTC, MadPennyStocks, StockEgg, InvestorsUnderground, Investors Alley, StockHotTips, InvestorGuide, Investor Ideas, StockRich and Willy Wizard reported earlier on Kandi Technologies Group Inc. (KNDI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Analysis by the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) has revealed that electric vehicle owners are more likely to install solar panels at home. On the other hand, the analysis discovered that having solar panels at home does not increase a homeowner’s chances of buying an electric car.

NREL polled 869 households in the San Francisco Bay Area and used this information as the survey’s main data source. According to Axios, the Bay Area leads the entire country in EV use with a 50% EV adoption rate. Electric vehicle owners are much more likely to install home solar panels to cut down on home-energy costs as they primarily charge their EVs at home.

While recharging an electric car generally costs less than refueling an internal combustion engine car, home solar panels can help EV owners reduce their charging costs even further by limiting the amount of energy they draw from the grid.

Shivam Sharda, a computational research scientist and NREL’s Center for Integrated Mobility Services says electric vehicles and solar panels “have a complementary nature” that may help improve energy systems resiliency and address concerns about power-management strategies and energy grid stability.

The survey involved a multi-institutional team of scientists from the National Renewable Energy Laboratory, the University of California Santa Barbara and the Lawrence Berkeley National Laboratory with Bingron Sun. Janet L. Ryena and Venu M. Garikapati from NREL coauthoring the paper. They conducted the survey in 2018 as part of the WholeTraveler Transportation Behavior Study and revisited its findings after the release of the Residential Energy Consumption study in 2022.

The interdisciplinary team noted that the relationship between electric cars and solar panels may still be complementary now that electric vehicles are significantly more prevalent on American roads. Twenty-five percent of EV owners had rooftop solar panels while only 8% of non-EV owners had installed solar panels at home.

Data from the 2018 study showed that more participants owned rooftop solar panels compared to electric cars (9.1% vs. 6.5%). Solar-panel technology was significantly cheaper than most electric vehicles at the time, and it had been around for much longer compared to EVs. The researchers also found that being aware of EV and solar technology and curious enough to ask about it were more likely to install solar panels.

Governments can hasten their efforts to meet emission targets by providing incentives to encourage the adoption of both electric cars and solar panels. Study authors say further research is necessary to understand the relationship between solar panels and electric cars. They published their findings in the journal “Renewable and Sustainable Energy Reviews.”

The findings of this study linking EV ownership to a willingness to install solar power may give EV makers such as Kandi Technologies Group Inc. (NASDAQ: KNDI) plenty of food for thought regarding how they can tweak their messaging in order to get more customers to switch to EVs.

Kandi Technologies Group Inc. (KNDI), closed Wednesday's trading session at $2.66, off by 0.374532%, on 95,840 volume. The average volume for the last 3 months is 438,862 and the stock's 52-week low/high is $2.22/$4.2699.

Alliance Resource Partners LP (ARLP)

The Online Investor, QualityStocks, Zacks, TradersPro, The Street, MarketBeat, InvestorPlace,, MarketClub Analysis, DividendStocks, TopStockAnalysts, The Wealth Report, Dividend Opportunities, TheStockAdvisor, MiningNewsWire, StreetAuthority Daily, Money Morning, The Motley Fool, Market Intelligence Center Alert, Early Bird, BUYINS.NET, Wealth Insider Alert, The Growth Stock Wire, TraderPower, Investing Daily, Trading Concepts, TheStockAdvisors, TheOptionSpecialist, Rick Saddler, Daily Wealth, SmarTrend Newsletters, Daily Trade Alert, Louis Navellier, Daily Markets, FNNO Newsletters, FreeRealTime, Greenbackers, Insider Wealth Alert, Eagle Financial Publications, Investment U, Investor Update,, Leeb's Market Forecast, Top Pros' Top Picks, TheTradingReport, TheStreet Offers, Money and Markets, Short Term Wealth, StockEarnings, StreetInsider and Trades Of The Day reported earlier on Alliance Resource Partners LP (ARLP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

For the first time in Europe’s history, wind-powered energy generation surpassed electricity from coal in the fourth quarter of 2023. Energy think tank Ember found that European power producers used wind power sites to generate a record 193 terawatt hours (TWh) of electricity from October to December 2023 compared to 154 TWh from coal power plants.

Last year’s final quarter saw wind generation increase by more than 20% compared to the same time window in 2022, even though the wind installation industry was constrained by factors such as high financing, material and labor costs. These factors could be mitigated by European Union policies enacted in late 2023 that offer incentives, such as shorter permit times for developers, and turbine manufacturing financing, which could widen the gap between wind- and coal-generated electricity even further.

Several European nations were forced to turn back to coal after Russia invaded Ukraine and exacerbated the ongoing energy crisis by cutting natural gas supplies to the rest of Europe. With shortages in the energy industry snowballing and costs rising amid a global energy crisis and approaching winter, nations such as Germany, the Netherlands and Austria fired up their previously shut down or restricted coal power plants to shore up their energy supplies.

Fortunately, EU nations also accelerated their efforts to deploy solar and wind-power generation technology, resulting in the displacement of 18 terawatt-hours (TWh) worth of natural gas consumption and a 31% year-on-year reduction in coal and fossil gas by August 2023.

Monthly wind energy generation also increased by 29% compared to August 2022 and year-on-year solar generation rose by 14%. However, even though renewable energy generation in the EU experienced admirable growth in 2023 and is predicted to widen its lead over coal this year, coal-fired electricity still has an uncertain outlook.

Whether or not wind can maintain its lead over coal in 2024 will depend on how the fossil fuel performs in 2023. Most EU nations are keen on completely cutting coal out of their energy mixes as part of global efforts to combat climate change, but the global energy crisis has consistently frustrated their efforts.

Germany, which was one of the countries that loosened restrictions on coal-fired generation after Russia cut natural gas supplies to Europe, coupled with Turkey and Poland, account for around one-half of the EU’s total coal-fired energy generation, will also help determine if the EU can keep its renewable energy momentum and reduce coal use.

This gradual shift away from coal puts coal production companies such as Alliance Resource Partners LP (NASDAQ: ARLP) on notice that they have to start thinking of other segments of the sector to venture into since coal is unlikely to remain viable in years to come.

Alliance Resource Partners LP (ARLP), closed Wednesday's trading session at $21.92, up 1.107%, on 413,328 volume. The average volume for the last 3 months is 13.14M and the stock's 52-week low/high is $17.05/$24.30.

Coinbase Global Inc. (COIN)

Schaeffer's, InvestorPlace, The Street, Prfmonline, MarketClub Analysis, QualityStocks, Greenbackers, MarketBeat, Zacks, INO Market Report, Kiplinger Today, Investopedia, OTCPicks, SmallCapVoice, Ceocast News, Early Bird, The Online Investor, CoolPennyStocks, HotOTC, The Wealth Report, Daily Trade Alert, Trades Of The Day, InsiderTrades, StockEgg, Stock Stars, Penny Invest, Stock Rich, StocksEarning, Top Pros' Top Picks, CNBC Breaking News, Top Gun, The Stock Psycho, StockEarnings, BestOtc, CryptoCurrencyWire, Wealth Daily, StockHotTips, FreeRealTime, HotShotStocks, BullRally, MadPennyStocks, FeedBlitz, PennyTrader Publisher, Energy and Capital, PennyStockVille, Summa Money, StockRich, Stockpalooza, Today's Financial News, Profit Confidential, Smartmoneytrading, PennyInvest, AlphaShark Trading, bullseyeoptiontrading, Cabot Wealth, Atomic Trades, Blaque Capital Stocks, CRWEWallStreet, Eagle Financial Publications, BloomMoney, Dynamic Wealth Report, Dawn Report, Pennybuster, Stock Analyzer, wyatt research newsletter, WiseAlerts, wealthmintrplus, Wealth Whisperer, TradersPro, TipRanks, StockMister, Penny Stock Finder, Stock Fortune Teller, Early Investing, Standout Stocks, Round Up the Bulls, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, Louis Navellier, Green Chip Stocks and Stock Traders Chat reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crypto company Ripple Labs has initiated a substantial share repurchase, amounting to $285 million, from early employees and investors, according to reliable sources acquainted with the situation. The financial maneuver, commonly referred to as a tender offer, has placed Ripple’s overall valuation at an impressive $11.4 billion.

The privately held entity confirmed that it will set aside $500 million for the all-inclusive buyback, which will include changing restricted stock into shares in addition to paying related taxes. Investors are limited to selling only 6% of their stake in this process.

Brad Garlinghouse, Ripple’s CEO, stated that the company intends to conduct periodic share buybacks to enhance liquidity for investors. Furthermore, Garlinghouse clarified that the company currently has no intentions to go public in the United States due to regulatory uncertainties. According to Garlinghouse, Ripple is in a strong financial position, having more than a billion dollars in cash plus a cryptocurrency portfolio in excess of $25 billion, predominantly made up of XRP coins.

The buyback strategy adopted by Ripple deviates from the conventional trajectory of going public, offering an alternative exit avenue for early investors. Unlike the typical route of an IPO, a buyback allows investors to liquidate their holdings without undergoing the complexities associated with a public offering.

By opting for a buyback, Ripple retains heightened flexibility and control over its operations. Public offerings entail navigating additional regulatory obligations, market volatility and managing investor expectations. In contrast, a buyback affords Ripple the ability to oversee investor relations without the intricacies linked to being a publicly traded company.

The move comes on the heels of a legal victory for Ripple in its prolonged legal dispute with the U.S. Securities and Exchange Commission (SEC). Last year, a court ruled that sales of XRP on exchanges didn’t constitute offerings of unregistered securities. Additionally, charges against Garlinghouse and former Ripple executive Christian Larsen were dismissed, absolving them of alleged violations related to XRP sales. Despite the SEC’s attempt at an interlocutory appeal, the request was denied in October.

Ripple Labs, which was founded in 2012, is focused on creating a system that facilitates international transactions and encourages XRP’s use. Garlinghouse acknowledged the challenges posed by the SEC lawsuit but highlighted that the majority of Ripple clients, constituting 95%, are non-U.S. financial institutions. In May of last year, the company acquired Metaco, a cryptocurrency custody company based in Switzerland, for $250 million, further increasing its global reach.

The buyback to be executed by Ripple Labs could suggest that the overall health of the crypto industry is improving after the crypto winter that posed an existential threat to it. The outlook of major actors such as Coinbase Global Inc. (NASDAQ: COIN) may therefore be more positive than it was at the peak of the headwinds, which pummeled the industry for most of 2022 and 2023.

Coinbase Global Inc. (COIN), closed Wednesday's trading session at $133.86, off by 0.014939%, on 8,133,091 volume. The average volume for the last 3 months is 136,463 and the stock's 52-week low/high is $46.43/$187.39.

The QualityStocks Company Corner

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global specialist in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 on the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of GLP-1 drug, semaglutide

The results showed improved delivery of semaglutide to the bloodstream, with the drug showing approximately 44% higher levels than the control 24 hours after ingestion of a single dose

DehydraTECH GLP-1 processed semaglutide also proved to be better tolerated than the control, with the latter resulting in some cases of moderate nausea and diarrhea

This milestone brings Lexaria closer to tapping into the diabetes and weight loss treatment market and sets the company up for what is expected to be its best year

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the final results from its recently completed human Pilot Study #1 that sought to evaluate the effectiveness of its patented DehydraTECH(TM) technology on the oral delivery of the glucagon-like peptide-1 ("GLP-1") drug semaglutide, available commercially in the branded product Rybelsus(R). The drug is approved by the Food and Drug Administration ("FDA"), given its role in promoting insulin production in the body, which ultimately reduces blood glucose (

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $1.63, up 5.1613%, on 228,683 volume. The average volume for the last 3 months is 161 and the stock's 52-week low/high is $0.6488/$3.5953.

Recent News

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI), a leading player in the digital asset landscape bridging the gap between traditional finance and decentralized finance, is featured in a recent interview released from Proactive. During the interview, Diamond Lake Minerals CEO Brian J. Esposito talked with Proactive host Steve Darling about the company's plans for 2024. During the discussion, Esposito explained that Diamond Lake Minerals employs an innovative approach, operating as a parent umbrella conglomerate with multiple subsidiaries spanning various industries. Esposito noted that the company goal is to emulate the structure of General Electric, which is recognized for its diversified portfolio across industries. Esposito went on to note that what differentiates DLMI is its incorporation of a security token element in each of its subsidiaries, an approach that allows global investors to participate in revenue or profit shares in a regulated and compliant environment.

"We're in the security token world," said Diamond Lake Minerals CEO Brian J. Esposito during the interview. "Security tokens resemble stocks; they resemble traditional securities, but on a blockchain, in a new future vision of where technology is going for asset allocation and participating in those assets. . . . There's too many friction points in getting into this digital asset space present day. And until you can buy digital tokens on your Charles Schwab account, your Morgan Stanley account, any brokerage account — that's when it gets mainstream. So what I intend us to be in building businesses traditionally and all these subsidiaries, but also having that digital component that allows someone to say, ‘Hey, I'm in the digital asset space. I own DLMI.' It was a very familiar process. They bought into a company. They believed in our vision. They believed in our strategy and our team. And we are participating in that digital securities industry."

To view the full interview, visit

To view the full press release, visit

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Wednesday's trading session at $5.25, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $3.5953/$.

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

MTPP secured 70% of the acquisition and 100% of the construction costs for Hamptons development projects

Target returns estimated at 20-30% per transaction with an anticipated timeline of 15-18 months for each project

Recently filed Regulation A offering to raise $10 million

Highly diversified portfolio includes investments in PropTech and mixed-use properties

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company, has recently secured debt capital commitments covering 70% of the acquisition and 100% of the construction costs for its Hamptons development projects.

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.


The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Wednesday's trading session at $0.075, even for the day, on 10,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0083/$0.1898.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month's Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and investors. The event agenda features more than 40 presentations from leading public companies as well as panel discussions and interactive sessions focused on addressing the latest trends and innovations in investor relations and technology. Puerto Rico was chosen as the site because it is home to many family offices, funds and wealthy investors because of its favorable tax benefits, being one of the only places in the world where U.S. citizens can move and pay virtually no federal or state income taxes. "GEMXX Corporation is thrilled to participate in this year's Sequire Investor Summit and looks forward to sharing its knowledge and expertise with attendees," said GEMXX president Richard Clowater in the press release. "Join us for an exciting and informative event that promises to be a highlight of the year for funds, companies and investors alike. Our revenue model is perfect for the ever-evolving ‘mine to consumer' markets emerging globally."

To view the full press release, visit

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.


GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Wednesday's trading session at $0.026, even for the day, on 237,604 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.023/$0.798.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, has released a report on its financial results for the 12-month period ended Sept. 30, 2023; the company also reported on its current business operations. In the report, the company noted key achievements throughout the year, including the company recording its first revenues of $366,000 and delivering vehicles valued at $652,200 to Randy Marion Automotive for resale in September; the production of Class 3 (the Mullen THREE) vehicles beginning in August 2023 and production Class 1 (the Mullen ONE) beginning in November 2023; and by year-end delivering 100 Class 1 vehicles and invoicing for $3.3 million to the Randy Marion Automotive Group and delivering 141 Class 3 vehicles and invoicing for $9.2 million to Randy Marion Automotive Group. The company also opened a battery module and pack development facility focused on scaling U.S.-made EV battery module and pack production and received federal EPA and NHTSA certification for its Class 1 and Class 3 vehicles; Mullen also received IRS approval as a "qualified manufacturer," meaning that buyers of Mullen vehicles are eligible for up to $7,500 in federal EV tax credits per vehicle. In addition, the company announced that the New York Power Authority, British Airways, University of North Carolina and MGT Lease Company all purchased Mullen's Campus Urban Delivery EV cargo vans during the year.

"Mullen has initiated production in Tunica and rolled out a significant number of vehicles in support of customer orders of Class 1 EV vans and Class 3 EV trucks and hurdled critical milestones of securing federal (‘NHTSA' and ‘EPA') certification and IRS approval for tax credits," said Mullen CEO and chair David Micher in the press release. "We completed a strategic purchase of EV battery pack manufacturing assets and showcased our innovations across the U.S. on the second leg of the ‘Strikingly Different' Test Drive Tour. Mullen is accelerating toward a promising future, both on the road and in the market."

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $10.52, off by 9.97%, on 539,135 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $6.95/$10080.00.

Recent News

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Astrotech (NASDAQ: ASTC) is an instrumentation company focused on commercializing its proprietary ATi Mass Spectrometer Technology(TM) that is now used in airports and agriculture applications around the world. The company today announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Astrotech continues to expand its ATi Mass Spectrometer Technology into new markets and recently launched its newest Pro-Control-1000(TM) product line of instrumentation designed to improve chemical manufacturing efficiencies. Astrotech also announced the formation of its newest wholly owned subsidiary, Pro-Control Inc., which has an exclusive ATi field-of-use license for worldwide chemical manufacturing and process control applications. Under the client partner relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outletsvarious newsletterssocial media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for Astrotech.

To view the full press release, visit

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.


Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Wednesday's trading session at $7.27, off by 1.8893%, on 717 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate Energy, a publicly traded distributed energy solutions company, has announced one addition to its C-suite team and two additions to its board of directors

Johan Themaat will serve as the company's new CFO, while Dr. Christine Gulbranson and Alina Zagaytova will serve on the board of directors

Correlate's management is confident that these appointments will play a pivotal role in the company's continued success, as well as its commitment to sustainable energy solutions

It is also confident that they will help assert the company's position as a leader in the industry, even as it works toward providing clean energy solutions

Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America's unstoppable trend toward decentralized energy generation, has announced notable additions to its c-suite team, as well as its board of directors. This follows the successful close of the 2023 calendar year and the commencement of what is set to be the company's biggest year yet. Its management is confident that these appointments will play a pivotal role in Correlate's continued success and its commitment to sustainable energy solutions (

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Wednesday's trading session at $2.2, off by 0.900901%, on 8,108 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3501/$2.35.

Recent News

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

Turbo Energy S.A. (NASDAQ: TURB), a leader in the field of photovoltaic energy storage, is joining with Solar360 in what it calls "a disruptive proposition in the solar photovoltaic self-consumption sector" designed to "maximize user savings and provide energy when it is needed, not just when the sun is shining." According to the announcement, Turbo Energy will serving as a technology provider and Solar360 will act as an energy services promoter in the strategic alliance. Solar360 will install intelligent batteries produced by Turbo Energy in homes, commercial areas and industries across the country. Called Sunbox, Solar360 has already launched the Turbo Energy product, which is all-in-one device that combines an inverter, battery and software. The device is designed to manage and store photovoltaic energy through a digital platform equipped with artificial intelligence algorithms that maximize energy savings and provide personalized performance for the user. Solar360 is a joint venture of Repsol and Telefónica España that develops the photovoltaic self-consumption business with comprehensive solutions for individual customers, communities of neighbors and companies. "We are delighted that a market leader like Solar360 has chosen our Sunbox device as a distinctive and innovative product for their value proposition," said Turbo Energy CEO Mariano Soria in the press release. "We are excited about this partnership and believe it will bring value to both sides as well as to a broad variety of consumers."

To view the full press release, visit

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.


Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.


The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Wednesday's trading session at $0.95, off by 3.0711%, on 5,559 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.95/$7.90.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, will be participating in this month's Needham Growth Conference. D-Wave, which is the world's first commercial supplier of quantum computers, will be represented at the conference by CEO Alan Baratz and CFO John Markovich, who are slated to present at 3 p.m. ET on Jan. 19, 2024. A recording of the presentation will be available on the company's website following the presentation. In addition, members of the D-Wave management team will be available for one-on-one meetings with investors.

To view the presentation, visit

To view the full press release, visit

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer


With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service


D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $0.7083, off by 1.9518%, on 1,256,085 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3962/$3.20.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced completion of planned enrollment in its global potentially pivotal study evaluating Berubicin, the Company's novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier, for the treatment of GBM, an aggressive and incurable form of brain cancer. The potentially pivotal study of Berubicin is a multicenter, open-label, randomized controlled study in adult patients with recurrent GBM (WHO Grade IV) after failure of standard first-line therapy and compared to Lomustine. The study has enrolled 247 patients across 46 clinical trial sites in the U.S., Italy, France, Spain, and Switzerland. The primary endpoint of the study is Overall Survival (OS), a rigorous endpoint the FDA has recognized as the basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $0.7065, off by 1.9295%, on 188,168 volume. The average volume for the last 3 months is 107,552 and the stock's 52-week low/high is $0.6105/$4.40.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

A massive cache of ancient genomes has helped researchers trace the origins of a wide variety of the genetic traits that occur in modern Europeans. According to the ancient DNA, characteristics such as an increased risk of developing multiple sclerosis may have reached Europe more than 45,000 years ago in the genomes of people who migrated to the European continent in three distinct waves. The research findings suggest that differences in the dispersal patterns of ancient migrants may have resulted in some of the regional variation seen in specific traits, contradicting the theory that genetic differences could have have occurred due to adaptations triggered by settling in different locations. This genealogical connection could give drug makers such as Clene Inc. (NASDAQ: CLNN) extra insights to mull over as they work to bring to market novel treatments targeting MS and other such neurodegenerative ailments.

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.


CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Wednesday's trading session at $0.486, off by 4.7059%, on 1,150,736 volume. The average volume for the last 3 months is 901,460 and the stock's 52-week low/high is $0.25/$1.99.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (NASDAQ: FRGT), a technology company specializing in the development of innovative solutions to optimize and automate the supply chain process through its custom-developed F8App platform, has entered into a contract with Kawasaki Motores de Mexico for cross-border logistics services. According to the announcement, Fr8App is already orchestrating the cross-border logistics for Kawasaki's popular Jet Ski models, which has provided an opportunity to demonstrate the platform's adaptability and efficiency in handling diverse transportation requirements. In a selection that goes beyond simple technology adoption, Kawasaki Motores de Mexico officials noted that Fr8App was chosen because the company aligns seamlessly with Kawasaki's core values of innovation and efficiency and represents "a strategic leap forward" in how Kawasaki approaches logistics operations. A division of Kawasaki Heavy Industries Ltd., Kawasaki Motores de Mexico has established a 120-year legacy of providing cutting-edge transportation systems for the 21st century.

"At Freight Technologies, we take immense pride not only in what we do but also in being chosen by global industries to revolutionize cross-border logistics," said Fr8Tech CEO Javier Selgas in the press release. "This contract with Kawasaki Motores de Mexico is a testament to our commitment to delivering cutting-edge solutions to a wide variety of industries. We believe that by securing a contract with Kawasaki Motores de Mexico, we also gain a chair at the table for a broader set of opportunities with many of the Kawasaki companies across North America. This strategy has served us well with other conglomerates and represents an inroad for us into additional opportunities with a large multinational conglomerate."

To view the full press release, visit

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.


Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Wednesday's trading session at $0.3155, off by 5.8771%, on 1,995,376 volume. The average volume for the last 3 months is 4.506M and the stock's 52-week low/high is $0.252/$6.70.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.